Merit Financial Group, LLC has disclosed its latest 13F-HR filing, revealing a substantial portfolio valued at approximately $17.9 billion as of September 30, 2026. This filing is crucial as it provides insights into the firm's investment strategies and positions across various sectors, particularly in healthcare and technology.

The report shows that Merit Financial Group has made significant investments in well-known companies, including Abbott Laboratories and 3M. These holdings reflect the firm's diverse investment approach and its focus on sectors that are likely to drive future growth.

Background

Merit Financial Group, LLC, incorporated in Delaware, operates as an asset management firm. The company has been active in filing various reports with the SEC, including multiple 13F-HR submissions. The most recent filing, dated November 6, 2026, is part of a series of quarterly reports that provide transparency regarding its investment activities.

What the Filing Says

The filing, accession number 0001621225-26-000008, highlights that the total value of the portfolio managed by Merit Financial Group is approximately $17,906,083,461. The report includes a comprehensive list of holdings, detailing the number of shares and the investment discretion exercised by the firm.

Impact

This filing may impact various stakeholders, including investors and analysts who track the performance of asset management firms. The disclosure of significant holdings in major companies like Abbott Laboratories and 3M may influence market perceptions and investment strategies among competitors and market participants.

What's Next

The filing does not specify any immediate next steps or actions following this report. However, stakeholders will likely monitor future filings for updates on portfolio changes and performance.